G-III Apparel Group, Ltd. (GIII) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for G-III Apparel Group, Ltd. (GIII).

Download S&P Stocks on Google Play Download S&P Stocks on the App Store

Equity Overview

Price & Market Data

Price: $28.14

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $1,187,206,528

Daily Volume: 0

Performance Metrics

1 Week: 4.18%

1 Month: -4.42%

3 Months: -3.60%

6 Months: 2.36%

1 Year: 16.09%

YTD: -2.83%

Company Details

Employees: 4500

Sector: Consumer non-durables

Industry: Apparel/Footwear

Country: United States

Details

G-III Apparel Group, Ltd. designs, sources, and markets women's and men's apparel in the United States and internationally. It operates through two segments, Wholesale Operations and Retail Operations. The company offers outerwear, dresses, sportswear, swimwear, women's suits, performance wear, suit separates, athleisure, jeans, handbags, footwear, accessories, small leather goods, cold weather accessories, and luggage. It markets apparel and other products under the its owned brands, including Andrew Marc, DKNY, Donna Karan, Eliza J, G.H. Bass, G-III for Her, G-III Sports by Carl Banks, Jessica Howard, Karl Lagerfeld, Karl Lagerfeld Paris, Marc New York, Sonia Rykiel, Vilebrequin, and Wilsons Leather; and under its licensed brands, such as BCBG, Calvin Klein, Champion, Cole Haan, Converse, Dockers, French Connection, Halston, Kenneth Cole, Kensie, Levi's, Margaritaville, Nautica, Tommy Hilfiger, and Vince Camuto. The company also engages in licensed team sports business that has partnerships with the National Football League, National Basketball Association, Major League Baseball, and National Hockey League, as well as U.S. colleges and universities. It distributes its products through retailers, digital channels, and online retail partners. G-III Apparel Group, Ltd. was founded in 1956 and is based in New York, New York.

Selected stocks

Prestige Consumer Healthcare Inc. (PBH)

Pacira BioSciences, Inc. (PCRX)

PTC Therapeutics, Inc. (PTCT)